{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T08:55:37Z","timestamp":1786870537014,"version":"build-2736575974"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2019.00238","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T15:38:35Z","timestamp":1559576315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Local Drug Delivery for the Treatment of Neurotology Disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Fabrice","family":"Piu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathie M.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"B1","article-title":"Clinical development of intratympanic sustained exposure formulation of the NMDA receptor antagonist gacyclidine for the treatment of tinnitus","author":"Anderson","year":"2019","journal-title":"Proceedings of the 42nd Annual MidWinter Meeting - Association for Research in Otolaryngology"},{"key":"B2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archotol.131.2.113","article-title":"Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: Does it work?","volume":"131","author":"Araujo","year":"2005","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/00005537-199811000-00017","article-title":"Hearing results of intratympanic steroid treatment of endolymphatic hydrops.","volume":"108","author":"Arriaga","year":"1998","journal-title":"Laryngoscope"},{"key":"B4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: the state of the art.","volume":"21","author":"Bala","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.otc.2004.04.003","article-title":"The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption.","volume":"37","author":"Banerjee","year":"2004","journal-title":"Otolaryngol. Clin. North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1097\/MLG.0b013e3181461f92","article-title":"AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis.","volume":"117","author":"Barkdull","year":"2007","journal-title":"Laryngoscope"},{"key":"B7","first-page":"1","article-title":"Meniere\u2019s disease.","volume":"3","author":"Barritt","year":"2008","journal-title":"XPharm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MAO.0b013e318168da7a","article-title":"Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.","volume":"29","author":"Battaglia","year":"2008","journal-title":"Otol. Neurotol."},{"key":"B9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph.","volume":"28","author":"Bird","year":"2007","journal-title":"Otol. Neurotol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/MAO.0b013e3182255933","article-title":"Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph.","volume":"32","author":"Bird","year":"2011","journal-title":"Otol. Neurotol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/jfb9010011","article-title":"Formulation of poloxamers for drug delivery.","volume":"9","author":"Bodratti","year":"2018","journal-title":"J. Funct. Biomater."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.2147\/IJN.S82944","article-title":"Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochlea.","volume":"10","author":"Bu","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"B13","first-page":"133","article-title":"Tinnitus: ediology, classification, characteristics, and treatment.","volume":"8","author":"Chan","year":"2009","journal-title":"Discov. Med."},{"key":"B14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00129492-200101000-00005","article-title":"Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation.","volume":"22","author":"Chandrasekhar","year":"2001","journal-title":"Otol. Neurotol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00016480310001042","article-title":"High variability of perilymphatic entry of neutral molecules through the round window.","volume":"123","author":"Chelikh","year":"2003","journal-title":"Acta Otolaryngol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.09.003","article-title":"Inner ear drug delivery via a reciprocating perfusion system in the guinea pig.","volume":"110","author":"Chen","year":"2005","journal-title":"J. Control Release"},{"key":"B17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2006.05.006","article-title":"AM-111 protects against permanent hearing loss from impulse noise trauma.","volume":"226","author":"Coleman","year":"2007","journal-title":"Hear. Res."},{"key":"B18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.1999.tb08652.x","article-title":"Treatment of acoustic trauma.","volume":"884","author":"D\u2019aldin","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.amjoto.2017.12.016","article-title":"Safety and efficacy of intratympanic ciprofloxacin otic suspension post-tubes in a real-world pediatric population.","volume":"39","author":"Dohar","year":"2018","journal-title":"Am. J. Otolaryngol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics.","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijpharm.2015.08.015","article-title":"Recent advances in local drug delivery to the inner ear.","volume":"494","author":"El Kechai","year":"2015","journal-title":"Int. J. Pharm."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1097\/01.mlg.0000183020.32435.59","article-title":"Novel strategy for treatment of inner ears using a biodegradable gel.","volume":"115","author":"Endo","year":"2005","journal-title":"Laryngoscope"},{"key":"B23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3109\/00016489.2015.1058534","article-title":"Local treatment of the inner ear: a study of three different polymers aimed for middle ear administration.","volume":"135","author":"Engmer Berglin","year":"2015","journal-title":"Acta Otolaryngol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archotol.1951.03750070060005","article-title":"Transtympanic injection of anesthetics for the treatment of Meniere\u2019s syndrome.","volume":"54","author":"Ersner","year":"1951","journal-title":"AMA Arch. Otolaryngol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.heares.2018.03.003","article-title":"Preclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111).","volume":"368","author":"Eshraghi","year":"2018","journal-title":"Hear. Res."},{"key":"B26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1567201811666140118224616","article-title":"Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear.","volume":"11","author":"Feng","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"B27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10544-008-9265-5","article-title":"Local drug delivery with a self-contained, programmable, microfluidic system.","volume":"11","author":"Fiering","year":"2009","journal-title":"Biomed. Microdevices"},{"key":"B28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","article-title":"Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere\u2019s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.","volume":"133","author":"Garduno-Anaya","year":"2005","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.otohns.2007.04.013","article-title":"Distribution of PLGA nanoparticles in chinchilla cochleae.","volume":"137","author":"Ge","year":"2007","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00405-004-0772-6","article-title":"Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.","volume":"262","author":"Gouveris","year":"2005","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B31","first-page":"43","article-title":"The round window membrane under normal and pathological conditions.","volume":"493","author":"Goycoolea","year":"1992","journal-title":"Acta Otolaryngol. Suppl."},{"key":"B32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/000164801300366552","article-title":"Clinical aspects of round window membrane permeability under normal and pathological conditions.","volume":"121","author":"Goycoolea","year":"2001","journal-title":"Acta Otolaryngol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/000348940311200701","article-title":"Noise-induced autoimmune sensorineural hearing loss.","volume":"112","author":"Gupta","year":"2003","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"B34","article-title":"Meniere\u2019s disease","author":"Harris","year":"2007","journal-title":"Handbook of the Senses"},{"key":"B35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.mlg.0000245058.11866.15","article-title":"Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.","volume":"117","author":"Haynes","year":"2007","journal-title":"Laryngoscope"},{"key":"B36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.heares.2008.06.003","article-title":"Localized cell and drug delivery for auditory prostheses.","volume":"242","author":"Hendricks","year":"2008","journal-title":"Hear. Res."},{"key":"B37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.otohns.2004.09.138","article-title":"Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.","volume":"132","author":"Herr","year":"2005","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1177\/014556130608500811","article-title":"Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Meniere\u2019s disease.","volume":"85","author":"Hill","year":"2006","journal-title":"Ear Nose Throat J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000358165","article-title":"Sustained Release of Triamcinolone Acetonide from an Intratympanically Applied Hydrogel Designed for the Delivery of High Glucocorticoid Doses.","volume":"19","author":"Honeder","year":"2014","journal-title":"Audiol. Neurootol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/lary.20713","article-title":"Sustained delivery of lidocaine into the cochlea using poly lactic\/glycolic acid microparticles.","volume":"120","author":"Horie","year":"2010","journal-title":"Laryngoscope"},{"key":"B41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000241894","article-title":"Intratympanic Steroids for Inner Ear Disorders: A Review.","volume":"14","author":"Hu","year":"2009","journal-title":"Audiol. Neurootol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s10162-002-2036-8","article-title":"Distribution of gentamicin in the guinea pig inner ear after local or systemic application.","volume":"4","author":"Imamura","year":"2003","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0378-5955(92)90030-Q","article-title":"Permeability changes of the blood-labyrinth barrier measured in vivo during experimental treatments.","volume":"61","author":"Inamura","year":"1992","journal-title":"Hear. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/00016480902725197","article-title":"Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs.","volume":"129","author":"Inaoka","year":"2009","journal-title":"Acta Otolaryngol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mlg.0000200791.77819.eb","article-title":"Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel.","volume":"116","author":"Iwai","year":"2006","journal-title":"Laryngoscope"},{"key":"B46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000111780","article-title":"Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation.","volume":"13","author":"James","year":"2008","journal-title":"Audiol. Neurootol."},{"key":"B47","first-page":"72","article-title":"Blood-labyrinth barrier and fluid dynamics of the inner ear.","volume":"7","author":"Juhn","year":"2001","journal-title":"Int. Tinnitus J."},{"key":"B48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/DDC-100102137","article-title":"In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease.","volume":"25","author":"Kelly","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/j.1365-2826.2008.01792.x","article-title":"Meniere\u2019s attacks occur in the inner ear with excessive vasopressin type-2 receptors.","volume":"20","author":"Kitahara","year":"","journal-title":"J. Neuroendocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/MLG.0b013e3181651c4a","article-title":"Effects of endolymphatic sac drainage with steroids for intractable Meniere\u2019s disease: a long-term follow-up and randomized controlled study.","volume":"118","author":"Kitahara","year":"","journal-title":"Laryngoscope"},{"key":"B51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00129492-200107000-00011","article-title":"Targeted topical steroid therapy in sudden sensorineural hearing loss.","volume":"22","author":"Kopke","year":"2001","journal-title":"Otol. Neurotol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/MAO.0000000000001227","article-title":"Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of Meniere\u2019s disease: randomized phase 2b safety and efficacy trial.","volume":"37","author":"Lambert","year":"2016","journal-title":"Otol. Neurotol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/MAO.0b013e318263d35d","article-title":"A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Meniere\u2019s disease.","volume":"33","author":"Lambert","year":"2012","journal-title":"Otol. Neurotol."},{"key":"B54","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/MAO.0b013e31811f40db","article-title":"Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel.","volume":"28","author":"Lee","year":"2007","journal-title":"Otol. Neurotol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2003.12.029","article-title":"Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo.","volume":"96","author":"Lee","year":"2004","journal-title":"J. Control Release"},{"key":"B56","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/003655402_000028037","article-title":"Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study.","volume":"122","author":"Lefebvre","year":"2002","journal-title":"Acta Otolaryngol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/MAO.0000000000001786","article-title":"Permeation enhancers for intratympanically-applied drugs studied using fluorescent dexamethasone as a marker.","volume":"39","author":"Li","year":"2018","journal-title":"Otol. Neurotol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.apsb.2013.02.003","article-title":"Current strategies for drug delivery to the inner ear.","volume":"3","author":"Liu","year":"2013","journal-title":"Acta Pharm. Sin. B"},{"key":"B59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/path.2102","article-title":"Ageing and hearing loss.","volume":"211","author":"Liu","year":"2007","journal-title":"J. Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/0003489415599001","article-title":"Randomized clinical trial of a sustained-exposure ciprofloxacin for intratympanic injection during tympanostomy tube surgery.","volume":"125","author":"Mair","year":"2015","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamaoto.2016.0001","article-title":"Safety and efficacy of intratympanic ciprofloxacin otic suspension in children with middle ear effusion undergoing tympanostomy tube placement: two randomized clinical trials.","volume":"142","author":"Mair","year":"2016","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"B62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/AUD.0b013e3181c351f2","article-title":"Drug delivery for treatment of inner ear disease: current state of knowledge.","volume":"31","author":"McCall","year":"2009","journal-title":"Ear Hear."},{"key":"B63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/AUD.0b013e3181c351f2","article-title":"Drug delivery for treatment of inner ear disease: current state of knowledge.","volume":"31","author":"MCcall","year":"2010","journal-title":"Ear Hear."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/MAO.0b013e31818658ea","article-title":"Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures.","volume":"29","author":"Mikulec","year":"2008","journal-title":"Otol. Neurotol."},{"key":"B65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/03655230601065332","article-title":"Drug delivery systems for the treatment of sensorineural hearing loss.","volume":"127","author":"Nakagawa","year":"2007","journal-title":"Acta Otolaryngol. Suppl."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0219-x","article-title":"A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.","volume":"12","author":"Nakagawa","year":"2014","journal-title":"BMC Med."},{"key":"B67","year":"2000","journal-title":"Sudden Deafness."},{"key":"B68","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1044\/2016_JSLHR-H-15-0365","article-title":"Economic impact of hearing loss and reduction of noise-induced hearing loss in the United States.","volume":"60","author":"Neitzel","year":"2017","journal-title":"J. Speech Lang. Hear. Res."},{"key":"B69","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.mao.0000169780.84588.a5","article-title":"Delivery of neurotrophin-3 to the cochlea using alginate beads.","volume":"26","author":"Noushi","year":"2005","journal-title":"Otol. Neurotol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier.","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-5955(88)90111-6","article-title":"Volume flow rate of perilymph in the guinea-pig cochlea.","volume":"35","author":"Ohyama","year":"1988","journal-title":"Hear Res."},{"key":"B72","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.heares.2005.10.013","article-title":"Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes.","volume":"212","author":"Paasche","year":"2006","journal-title":"Hear Res."},{"key":"B73","first-page":"807","article-title":"Sudden sensorineural hearing loss: have we got a cure?","volume":"37","author":"Panda","year":"2008","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/0194599816645526","article-title":"Phase 3 trials of thermosensitive ciprofloxacin gel for middle ear effusion in children with tubes.","volume":"155","author":"Park","year":"2016","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B75","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/MLG.0b013e31815f8e41","article-title":"A novel controlled local drug delivery system for inner ear disease.","volume":"118","author":"Paulson","year":"2008","journal-title":"Laryngoscope"},{"key":"B76","first-page":"442","article-title":"[Clinical investigation of different routes of administration of dexamethasone on sudden deafness].","volume":"22","author":"Peng","year":"2008","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"B77","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/17425247.2018.1444026","article-title":"Intracochlear drug delivery systems: a novel approach whose time has come.","volume":"15","author":"Peppi","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"B78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/MAO.0b013e3182009d29","article-title":"OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders.","volume":"32","author":"Piu","year":"2011","journal-title":"Otol. Neurotol."},{"key":"B79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/00016480510037898","article-title":"Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.","volume":"125","author":"Plontke","year":"2005","journal-title":"Acta Otolaryngol."},{"key":"B80","first-page":"369","article-title":"Pharmacokinetic considerations in intratympanic drug delivery to the inner ear.","volume":"56","author":"Plontke","year":"2002","journal-title":"Acta Otorhinolaryngol. Belg."},{"key":"B81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00106-016-0285-9","article-title":"Intracochlear drug delivery in combination with cochlear implants: current aspects.","volume":"65","author":"Plontke","year":"2016","journal-title":"HNO"},{"key":"B82","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/lary.20074","article-title":"Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.","volume":"119","author":"Plontke","year":"2009","journal-title":"Laryngoscope"},{"key":"B83","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/MLG.0b013e318058a06b","article-title":"Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane.","volume":"117","author":"Plontke","year":"","journal-title":"Laryngoscope"},{"key":"B84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000095284","article-title":"Simulation of application strategies for local drug delivery to the inner ear.","volume":"68","author":"Plontke","year":"2006","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"B85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000097246","article-title":"Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model.","volume":"12","author":"Plontke","year":"","journal-title":"Audiol. Neurootol."},{"key":"B86","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.mao.0000235310.72442.4e","article-title":"Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects.","volume":"27","author":"Plontke","year":"2006","journal-title":"Otol. Neurotol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-1-4939-3615-1_21","article-title":"An overview of nanoparticle based delivery for treatment of inner ear disorders.","volume":"1427","author":"Pyykko","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.biomaterials.2009.01.015","article-title":"Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.","volume":"30","author":"Richardson","year":"2009","journal-title":"Biomaterials"},{"key":"B89","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejps.2009.11.003","article-title":"Use of the biodegradable polymer chitosan as a vehicle for applying drugs to the inner ear.","volume":"39","author":"Saber","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"B90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0385-8146(86)80002-5","article-title":"[Treatment of Meniere\u2019s disease. Middle ear infusion with lidocaine and steroid solution].","volume":"13","author":"Sakata","year":"1986","journal-title":"Auris Nasus Larynx"},{"key":"B91","first-page":"277","article-title":"Pharmacokinetics of drug entry into cochlear fluids.","volume":"105","author":"Salt","year":"2006","journal-title":"Volta Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000493846","article-title":"Dexamethasone and dexamethasone phosphate entry into perilymph compared for middle ear applications in guinea pigs.","volume":"23","author":"Salt","year":"2018","journal-title":"Audiol. Neurootol."},{"key":"B93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0378-5955(01)00223-4","article-title":"Quantification of solute entry into cochlear perilymph through the round window membrane.","volume":"154","author":"Salt","year":"2001","journal-title":"Hear Res."},{"key":"B94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0378-5955(91)90150-8","article-title":"Radial communication between the perilymphatic scalae of the cochlea, I: estimation by tracer perfusion.","volume":"56","author":"Salt","year":"","journal-title":"Hear Res."},{"key":"B95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-5955(91)90151-X","article-title":"Radial communication between the perilymphatic scalae of the cochlea, II: estimation by bolus injection of tracer into the sealed cochlea.","volume":"56","author":"Salt","year":"","journal-title":"Hear Res."},{"key":"B96","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1359-6446(05)03574-9","article-title":"Local inner-ear drug delivery and pharmacokinetics.","volume":"10","author":"Salt","year":"2005","journal-title":"Drug Discov. Today"},{"key":"B97","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000241892","article-title":"Principles of local drug delivery to the inner ear.","volume":"14","author":"Salt","year":"2009","journal-title":"Audiol. Neurootol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.heares.2018.03.002","article-title":"Pharmacokinetic principles in the inner ear: influence of drug properties on intratympanic applications.","volume":"368","author":"Salt","year":"2018","journal-title":"Hear Res."},{"key":"B99","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5955(86)90011-0","article-title":"Direct measurement of longitudinal endolymph flow rate in the guinea pig cochlea.","volume":"23","author":"Salt","year":"1986","journal-title":"Hear Res."},{"key":"B100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1067\/mhn.2001.112310","article-title":"Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere\u2019s disease.","volume":"124","author":"Schoendorf","year":"2001","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B101","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.mao.0000185050.69394.48","article-title":"Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere\u2019s-associated sudden sensorineural hearing loss.","volume":"26","author":"Selivanova","year":"2005","journal-title":"Otol. Neurotol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000241898","article-title":"Development of a microfluidics-based intracochlear drug delivery device.","volume":"14","author":"Sewell","year":"2009","journal-title":"Audiol. Neurootol."},{"key":"B103","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0030-6665(20)30147-X","article-title":"The role of dexamethasone or streptomycin perfusion in the treatment of Meniere\u2019s disease.","volume":"30","author":"Shea","year":"1997","journal-title":"Otolaryngol. Clin. North Am."},{"key":"B104","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0030-6665(20)30398-4","article-title":"Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere\u2019s disease.","volume":"29","author":"Shea","year":"1996","journal-title":"Otolaryngol. Clin. North Am."},{"key":"B105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.otohns.2004.05.021","article-title":"Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity.","volume":"131","author":"Sheppard","year":"2004","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B106","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/014556139907800816","article-title":"Use of a new device, the MicroWick, to deliver medication to the inner ear.","volume":"78","author":"Silverstein","year":"1999","journal-title":"Ear Nose Throat J."},{"key":"B107","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/014556130908800207","article-title":"Dexamethasone inner ear perfusion for subclinical endolymphatic hydrops.","volume":"88","author":"Silverstein","year":"2009","journal-title":"Ear Nose Throat J."},{"key":"B108","first-page":"196","article-title":"Dexamethasone inner ear perfusion for the treatment of Meniere\u2019s disease: a prospective, randomized, double-blind, crossover trial.","volume":"19","author":"Silverstein","year":"1998","journal-title":"Am. J. Otol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/10915810802244595","article-title":"Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.","volume":"27","author":"Singh-Joy","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"B110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2005-870274","article-title":"[Treatment of sensorineural hearing loss in acute viral otitis media with intratympanic dexamethasone and hyaluronic acid in comparison with intravenous therapy].","volume":"85","author":"Stenner","year":"2006","journal-title":"Laryngorhinootologie"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/MAO.0000000000000466","article-title":"Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study.","volume":"35","author":"Suckfuell","year":"2014","journal-title":"Otol. Neurotol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0022215108002776","article-title":"Transtympanic gentamicin treatment using Silverstein MicroWick in Meniere\u2019s disease patients: long term outcome.","volume":"123","author":"Suryanarayanan","year":"2009","journal-title":"J. Laryngol. Otol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.addr.2008.08.001","article-title":"Inner ear drug delivery for auditory applications.","volume":"60","author":"Swan","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B114","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/lary.20209","article-title":"Proteomics analysis of perilymph and cerebrospinal fluid in mouse.","volume":"119","author":"Swan","year":"2009","journal-title":"Laryngoscope"},{"key":"B115","first-page":"1115","article-title":"Treatment of vertigo.","volume":"71","author":"Swartz","year":"2005","journal-title":"Am. Fam. Phys."},{"key":"B116","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/00016480410017459","article-title":"Localization of endotoxin in the inner ear following inoculation into the middle ear.","volume":"124","author":"Takumida","year":"2004","journal-title":"Acta Otolaryngol."},{"key":"B117","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/01.mlg.0000180174.81036.5a","article-title":"Drug delivery to the cochlea using PLGA nanoparticles.","volume":"115","author":"Tamura","year":"2005","journal-title":"Laryngoscope"},{"key":"B118","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00464276","article-title":"Permeability of the labyrinthine windows in guinea pigs.","volume":"233","author":"Tanaka","year":"1981","journal-title":"Arch. Otorhinolaryngol."},{"key":"B119","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/01945998941113P117","article-title":"Protein profile of human perilymph: in search of markers for the diagnosis of perilymph fistula and other inner ear disease.","volume":"111","author":"Thalmann","year":"1994","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1081\/DDC-120003853","article-title":"Alginate in drug delivery systems.","volume":"28","author":"Tonnesen","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B121","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MAO.0000000000000268","article-title":"Efficacy and Safety of AM-101 in the treatment of acute inner ear tinnitus-A double-blind, randomized, placebo-controlled phase II study.","volume":"35","author":"van de Heyning","year":"2014","journal-title":"Otol. Neurotol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.01.057","article-title":"In situ gelling hydrogels for pharmaceutical and biomedical applications.","volume":"355","author":"Van Tomme","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B123","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00016480601126952","article-title":"Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.","volume":"127","author":"Van Wijck","year":"2007","journal-title":"Acta Otolaryngol."},{"key":"B124","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000095897","article-title":"Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.","volume":"11","author":"Van Wijk","year":"2006","journal-title":"Audiol. Neurootol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000241896","article-title":"Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach.","volume":"14","author":"Wang","year":"2009","journal-title":"Audiol. Neurootol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/lary.21370","article-title":"Principles of inner ear sustained release following intratympanic administration.","volume":"121","author":"Wang","year":"2011","journal-title":"Laryngoscope"},{"key":"B127","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00405-009-1126-1","article-title":"Effects of extracochlear gacyclidine perfusion on tinnitus in humans: a case series.","volume":"267","author":"Wenzel","year":"2010","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2560\/9\/6\/065002","article-title":"Drug delivery to the inner ear.","volume":"9","author":"Wise","year":"2012","journal-title":"J. Neural Eng."},{"key":"B129","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.otohns.2005.03.081","article-title":"Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.","volume":"134","author":"Xenellis","year":"2006","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B130","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/mp800137z","article-title":"Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.","volume":"6","author":"Xu","year":"2009","journal-title":"Mol. Pharm."},{"key":"B131","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.MLG.0000163748.55350.89","article-title":"Effect of intratympanic dexamethasone on noise-induced temporary threshold shift.","volume":"115","author":"Yildirim","year":"2005","journal-title":"Laryngoscope"}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2019.00238\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T22:55:01Z","timestamp":1608159301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fncel.2019.00238\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":131,"alternative-id":["10.3389\/fncel.2019.00238"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2019.00238","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"article-number":"238"}}